Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis | Zendy

Paige W. Wolstencroft | Zendy; Livia CasciolaRosen | Zendy; David Fiorentino | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis

Author(s) -

Paige W. Wolstencroft,

Livia CasciolaRosen,

David Fiorentino

Publication year - 2018

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.2549

Subject(s) - medicine , hydroxychloroquine , dermatomyositis , autoantibody , dermatology , phenotype , immunology , pathology , covid-19 , antibody , disease , genetics , biology , gene , infectious disease (medical specialty)

Hydroxychloroquine sulfate is a commonly used medication for patients with dermatomyositis and has been associated with a uniquely elevated risk of adverse cutaneous reactions in this population. No studies to date have examined whether certain subsets of patients with dermatomyositis are at increased risk of experiencing a hydroxychloroquine-associated skin eruption.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research